Visible Uranium-Copper-Vanadium mineralization observed at surface, consistent with historical head grades of 0.21% Uranium, 2.0% Copper and 0.11% Vanadium1Potential 4-kilometre copper trend identified; historic...
Visible Uranium-Copper-Vanadium mineralization observed at surface, consistent with historical head grades of 0.21% Uranium, 2.0% Copper and 0.11% Vanadium1Potential 4-kilometre copper trend identified; historic...
PMET's premier James Bay - Quebec geology delivers further exploration success with 2.94% Li2O, 16.43% Cs2O, and 3,768ppm Ta2O5 in surface samples at its...
PMET's premier James Bay - Quebec geology delivers further exploration success with 2.94% Li2O, 16.43% Cs2O, and 3,768ppm Ta2O5 in surface samples at its...
PMET's premier James Bay - Quebec geology delivers further exploration success with 2.94% Li2O, 16.43% Cs2O, and 3,768ppm Ta2O5 in surface samples at its...
Learn how MemeToro uses AI agents, memecoin analytics, DeFi trading, and prediction markets to help beginners discover the best crypto presale opportunities early
Learn how MemeToro uses AI agents, memecoin analytics, DeFi trading, and prediction markets to help beginners discover the best crypto presale opportunities early
PEBBLE BEACH, Calif., Aug. 17, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, announced that it has officially launched its transformative “EAI + Crypto” Dual-Flywheel & Dual-Bridge Ecosystem Strategy — marking the beginning of a new chapter in AI mobility and Web3 integration.
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).
ROK Financial announces new loan pathways for pool and spa contractors heading into the 2025 season. By offering no credit check financing, fast approvals, and expanded loan ranges, the company addresses growing demand among small business owners with fair or poor credit histories. This initiative responds to the sharp rise in alternative lending searches and the increased pressure on contractors seeking reliable capital access as traditional banks tighten standards.
ROK Financial announces new loan pathways for pool and spa contractors heading into the 2025 season. By offering no credit check financing, fast approvals, and expanded loan ranges, the company addresses growing demand among small business owners with fair or poor credit histories. This initiative responds to the sharp rise in alternative lending searches and the increased pressure on contractors seeking reliable capital access as traditional banks tighten standards.
/NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES./
CSE: TEX | OTCQB: TRGEF | FRA: V6Y
VANCOUVER, BC,...
SINGAPORE, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we,” “us” or “our”), today announced its unaudited financial results for the first six months of fiscal year 2025.
DALLAS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HF Sinclair Corporation (NYSE and NYSE Texas: DINO) (the “Corporation”) today announced the pricing terms for its previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding notes listed in the table below (collectively, the “Notes” and each a “Series” of Notes). All other terms and conditions of the Tender Offer remain unchanged and are described in the Offer to Purchase, dated August 11, 2025 (the “Offer to Purchase”). Capitalized terms used in this news release and not defined herein have the meanings given to them in the Offer to Purchase.
VANCOUVER, BC, Aug. 15, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia") (TSXV:CAM) (OTCQB:CAMNF) is pleased to announce that is has closed its previously announced non-brokered...
CINCINNATI, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial results for the second quarter ended June 30, 2025.